Skip to main content

AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3,RANDOMIZED, DOUBLE-BLIND, 3-ARM STUDY TO INVESTIGATE IBUZATRELVIR INADULTS WITH SYMPTOMATIC COVID-19 WHO ARE SEVERELYIMMUNOCOMPROMISED

Open
  • Protocol code: C5091018
  • EudraCT code: No aplica
  • Research group: Infectious Diseases
  • Service: Infectious
  • Principal investigator:  Len Abad, Oscar
  • Pathology: Certes malalties infeccioses i parasitàries
  • Phase: Fase III